Daily non-political popular news in brief.
Quest for better breast cancer drugs
11-27-2006 · EurekAlert!Breast cancer sufferers could eventually benefit from high-tuned, tailor-made drug treatments that minimize side effects as a result of a joint initiative between computer scientists in Edinburgh and cellular biologists in Japan.
Read more »
Keywords: quest, breast, cancer, drugs, drug
« Previous | Next »
Similar news on "Quest for better breast cancer drugs":
- A new computational technique predicts side-effects of a major cancer drug
11-27-2007 · EurekAlert!
Researchers at the University of California San Diego have developed a novel computer technique to search for the side effects of major pharmaceuticals. The study, reported Nov. 30 in PLoS Computational Biology, relates to a class of drugs known as Select Estrogen Receptor Modulators, which includes tamoxifen, the most prescribed drug in the treatment of breast cancer.
Similar news · Read more »
- Latest drugs improve survival for metastatic breast cancer
07-23-2007 · EurekAlert!
Newer drug therapies available since the 1990s, in particular aromatase inhibitors, improve the survival of women with metastatic breast cancer in the general population, according to a new study.
Similar news · Read more »
- Blocking cancer-causing gene improves radiation effectiveness, Jefferson researchers find
11-08-2006 · EurekAlert!
Inhibiting a particular cancer-causing gene can enhance the cell-killing effects of radiation, a team of radiation oncologists and cancer biologists has found. Using a combination of zebrafish and antisense technology, they've shown that the drug flavopiridol works by blocking the activity of a gene, cyclin D1, which is overexpressed in about half of all breast cancers. Similar techniques in the future, the scientists say, may enable researchers to better gauge the effects of drugs.
Similar news · Read more »
- New biomarker predicts effectiveness of breast cancer drugs
12-07-2006 · EurekAlert!
University of Cincinnati researchers have identified a new way to predict when anti-estrogen drug therapies are inappropriate for patients with hormone-dependent breast cancer.Scientists say these findings could help physicians more accurately predict which tumors will respond to anti-estrogen therapy and improve long-term survival for breast cancer patients.
Similar news · Read more »
- Jefferson scientists identify protein key to breast cancer spread, potential new drug target
04-09-2007 · EurekAlert!
Researchers at the Kimmel Cancer Center at Jefferson have identified a protein that they say is key to helping a quarter of all breast cancers spread. The finding, reported online the week of April 9, 2007, in the journal Proceedings of the National Academy of Sciences, could be a potential target for new drugs aimed at stopping or slowing the growth and progression of breast cancer.
Similar news · Read more »
- Moving beyond tamoxifen: Drug discovery and the future of selective hormone receptor modulators
02-15-2008 · EurekAlert!
How did a failed contraceptive become the first targeted therapy for the treatment of breast cancer? The transformation of tamoxifen, from cast-off to lifesaver, laid the foundation for a new class of therapeutics -- selective estrogen receptor modulators. V. Craig Jordan, a researcher at the Fox Chase Cancer Center in Philadelphia, Jordan reports on efforts to use the lessons from tamoxifen to develop new hormone receptor-related drugs for both women and men.
Similar news · Read more »
- Study suggests newer breast cancer drug may protect heart
06-08-2007 · EurekAlert!
By uncovering how one breast cancer drug protects the heart and another does not, Duke University Medical Center researchers believe they may have opened up a new way to screen drugs for possible heart-related side effects and to develop new drugs.
Similar news · Read more »
- Mouse Tests Predict Drug Response In Relapsing Pancreatic Cancer Patients
10-12-2006 · ScienceDaily
By slicing up bits of patient tumors and grafting them into mice, Johns Hopkins Kimmel Cancer Center specialists have figured out how to accurately 'test drive' chemotherapy drugs to learn in advance which drug treatments offer each individual pancreatic cancer patient the best therapeutic journey.
Similar news · Read more »
- New cancer drug hope
10-26-2006 · EurekAlert!
Scientists helping to develop the next generation of cancer-beating drugs say they have had a major breakthrough with their latest results.
Similar news · Read more »
- Sunshine pill for prostate cancer in 2009
01-16-2007 · EurekAlert!
A drug based on vitamin D and is given to patients in the advanced stages of prostate cancer along with chemotherapy drugs could be availiable by 2009. Vitamin D from sunlight improves the prognosis of certain cancers, but taking natural levels of the vitamin has no effect. Novacea, the company that makes Asentar, produced a novel formulation that reproduces the healing effect without the dangerous side-effects of a vitamin D overdose.
Similar news · Read more »
